Cures Within Reach President and Chief Science Officer Keynote Speaker at MedCity INVEST

SKOKIE, Ill. - April 7, 2016 - PRLog -- Cures Within Reach (www.CuresWithinReach.org), the global philanthropic leader catalyzing repurposing research as a fast track to saving patients lives, will share insights about the evolution of new economic models to support repurposing research, including social impact investing, at MedCity INVEST on April 13, 2016.

Dr. Bruce Bloom, president and chief science officer at Cures Within Reach, will describe how financial instruments used in other business sectors can be repurposed in healthcare to deliver more treatments, reduce and manage direct healthcare costs, positively impact patients and payers, and provide opportunity for investors and industry in his keynote presentation, "Beg, Borrow and Steal: Repurposing Non-Healthcare Financial Instruments to Drive New Treatments to Patients."

"We desperately need an affordable, scalable and sustainable system to discover medical solutions for patients," said Dr. Bloom. "The current pharmaceutical profit model generally supports the development of new drugs or the repositioning of patent-protected pipeline compounds, so it's important for us to investigate repurposing financial structures used in other business sectors to accelerate generic drug and other repurposing research discovery."

Dr. Bloom directs the operation of Cures Within Reach, which is dedicated to improving patient quality and length of life by facilitating pilot clinical trials testing repurposed treatments designed to be immediately incorporated into clinical use. He and his team also founded CureAccelerator™, the global online repurposing research collaboration platform driving more treatments to more patients more quickly.

At MedCity INVEST, active investors connect with corporate business development executives to facilitate investment opportunities with over 40 of the most promising healthcare start-ups that span the biotech, medical device, digital health, diagnostics, pharma, and regenerative medicine sectors. Over 300 healthcare experts, industry leaders, active investors and entrepreneurs will be in attendance. For more information, visit http://events.medcitynews.com/invest/.

ABOUT CURES WITHIN REACH

Cures Within Reach (www.CuresWithinReach.org) works to catalyze repurposing research to quickly and affordably improve patient lives. We accomplish this through collaborations that connect researchers and funding, by facilitating crowd sourcing and community, and by identifying alternative financing models and incentives.

Cures Within Reach's repurposing research projects have generated 13 "new" treatments making an impact through off-label use in clinical practice or through a commercialization track.

ABOUT CUREACCELERATOR™

Cures Within Reach built CureAccelerator (www.CureAccelerator.org)to provide a global collaboration space and market for repurposing research that can deliver effective solutions to unsolved diseases. The CureAccelerator platform was built with a grant from the Robert Wood Johnson Foundation, to explore whether drugs, devices and nutriceuticals approved for one or more human diseases can be repurposed to create "new" treatments in other diseases. CureAccelerator has almost 1000 users who have proposed over 100 projects, of which more than a dozen are already funded and moving towards patient impact.

Visit us at www.cureswithinreach.org or follow us via Twitter.com/CuresWReach (http://www.twitter.com/CuresWReach), LinkedIn.com/company/cures-within-reach (http://www.linkedin.com/company/cures-within-reach), YouTube.com/cureswithinreach (http://www.youtube.com/cureswithinreach) or Facebook.com/CuresWithinReach (http://www.facebook.com/CuresWithinReach).